These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 7046321

  • 1. Discrimination of renovascular from essential hypertension by converting enzyme inhibition with an orally active compound.
    Fagard R, Amery A, Lijnen P, Roussel-Deruyck R.
    Acta Clin Belg; 1982; 37(1):13-22. PubMed ID: 7046321
    [No Abstract] [Full Text] [Related]

  • 2. A screening test for renovascular hypertension by means of orally active angiotensin I converting enzyme inhibitor, captopril (SQ 14225).
    Imai Y, Abe K, Otsuka Y, Sakurai Y, Yoshinaga K.
    Tohoku J Exp Med; 1980 Jul; 131(3):311-2. PubMed ID: 6998048
    [Abstract] [Full Text] [Related]

  • 3. Reactive hyper-reninaemia to angiotensin blockade identifies renovascular hypertension.
    Case DB, Atlas SA, Laragh JH.
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():313s-316s. PubMed ID: 232024
    [Abstract] [Full Text] [Related]

  • 4. Hypertension screening and treatment with angiotensin inhibitors. Saralasin and captopril.
    Zawada ET, Stinson J, Ramirez G.
    Postgrad Med; 1980 Oct; 68(4):89-92, 94-5, 98. PubMed ID: 6999479
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Use of captopril in the diagnosis of renal hypertension.
    McGrath BP, Matthews PG, Johnston CI.
    Aust N Z J Med; 1981 Aug; 11(4):359-63. PubMed ID: 7030291
    [Abstract] [Full Text] [Related]

  • 7. Captopril in renovascular hypertension: long-term use in predicting surgical outcome.
    Atkinson AB, Brown JJ, Cumming AM, Fraser R, Lever AF, Leckie BJ, Morton JJ, Robertson JI.
    Br Med J (Clin Res Ed); 1982 Mar 06; 284(6317):689-93. PubMed ID: 6802290
    [Abstract] [Full Text] [Related]

  • 8. Renal artery stenosis with normal angiotensin II values. Relationship between angiotensin II and body sodium and potassium on correction of hypertension by captopril and subsequent surgery.
    Atkinson AB, Brown JJ, Davies DL, Leckie B, Lever AF, Morton JJ, Robertson JI.
    Hypertension; 1981 Mar 06; 3(1):53-8. PubMed ID: 7009427
    [Abstract] [Full Text] [Related]

  • 9. [Inhibition of the angiotensin I converting enzyme with SQ-14225 (captopril) in the medical treatment of severe renovascular hypertension].
    Martínez Amenós A, Caralps A, Rama H, Sarrias X, Alsina J.
    Rev Clin Esp; 1981 Sep 30; 162(6):265-8. PubMed ID: 7036249
    [No Abstract] [Full Text] [Related]

  • 10. [Effect of captopril on renal vein plasma renin ratio--diagnosis and predicting response to surgery in renovascular hypertension].
    Takata M, Sugimoto T, Mikawa M, Yoshida K, Iuchi K, Iida H, Mizumura Y, Nakada T, Kawahara Y.
    Nihon Jinzo Gakkai Shi; 1983 Aug 30; 25(8):1017-26. PubMed ID: 6366302
    [No Abstract] [Full Text] [Related]

  • 11. Maximal discrimination of renovascular from essential hypertension by the saralasin test.
    Maxwell MH, Varady P, Zawada ET, Burkhalter JF, Waks U, Marks L.
    Clin Sci Mol Med Suppl; 1978 Dec 30; 4():297s-299s. PubMed ID: 282071
    [No Abstract] [Full Text] [Related]

  • 12. Effects of angiotensin I converting enzyme inhibitor (SQ 14,225) on the responses of blood pressure and steroid hormone to angiotensin II and ACTH infusion in hypertensive subjects.
    Ueda Y, Honda M, Hatano M.
    Jpn Circ J; 1982 Mar 30; 46(3):267-73. PubMed ID: 6278173
    [Abstract] [Full Text] [Related]

  • 13. Captopril in hypertension with renal artery stenosis and in intractable hypertension; acute and chronic changes in circulating concentrations of renin, angiotensins I and II and aldosterone, and in body composition.
    Atkinson AB, Brown JJ, Fraser R, Leckie B, Lever AF, Morton JJ, Robertson JI.
    Clin Sci (Lond); 1979 Dec 30; 57 Suppl 5():139s-143s. PubMed ID: 396067
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [The Saralasin test in the diagnosis of renovascular hypertension. Personal experience].
    Giuliani L, Martorana G, Giberti C.
    Minerva Nefrol; 1979 Dec 30; 26(4):623-8. PubMed ID: 396491
    [No Abstract] [Full Text] [Related]

  • 16. Diagnosis of unilateral renovascular hypertension: comparative effect of intravenous enalaprilat and oral captopril.
    Tunny TJ, Klemm SA, Hamlet SM, Gordon RD.
    J Urol; 1988 Oct 30; 140(4):713-5. PubMed ID: 2843688
    [Abstract] [Full Text] [Related]

  • 17. Role of aldosterone in experimental hypertension.
    McCaa RE, McCaa CS, Bengis RG, Guyton AC.
    J Endocrinol; 1979 May 30; 81(2):69P-78P. PubMed ID: 222873
    [No Abstract] [Full Text] [Related]

  • 18. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.
    Lechi A, Covi G, Capuzzo MG, Lechi C, Minuz P, Delva P, Scuro LA.
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov 30; 21(11):569-74. PubMed ID: 6317579
    [Abstract] [Full Text] [Related]

  • 19. A new syndrome: angiotensin-converting enzyme dysfunction syndrome: differential diagnosis and pathogenesis--case reports.
    Umeki S, Terao A, Sawayama T.
    Angiology; 1988 Jan 30; 39(1 Pt 1):58-67. PubMed ID: 3277490
    [Abstract] [Full Text] [Related]

  • 20. Reactive hyperreninemia in renovascular hypertension after angiotensin blockage with saralasin or converting enzyme inhibitor.
    Case DB, Laragh JH.
    Ann Intern Med; 1979 Aug 30; 91(2):153-60. PubMed ID: 464461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.